Lynne C. Fitzpatrick's most recent trade in CME Group Inc - Ordinary Shares - Class A was a trade of 4,348 Common Stock Class A done at an average price of $258.8 . Disclosure was reported to the exchange on Sept. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CME Group | Lynne C. Fitzpatrick | President and CFO | Grant, award, or other acquisition of securities at price $ 258.83 per share. | 15 Sep 2025 | 4,348 | 21,303 (0%) | 0% | 258.8 | 1,125,393 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.83 per share. | 15 Sep 2025 | 639 | 16,955 (0%) | 0% | 258.8 | 165,392 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.83 per share. | 15 Sep 2025 | 379 | 20,924 (0%) | 0% | 259.8 | 98,476 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Grant, award, or other acquisition of securities at price $ 258.68 per share. | 15 Mar 2025 | 1,110 | 18,164 (0%) | 0% | 258.7 | 287,135 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.68 per share. | 15 Mar 2025 | 492 | 17,672 (0%) | 0% | 258.7 | 127,271 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Grant, award, or other acquisition of securities at price $ 258.68 per share. | 15 Mar 2025 | 341 | 17,206 (0%) | 0% | 258.7 | 88,210 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.68 per share. | 15 Mar 2025 | 152 | 17,054 (0%) | 0% | 258.7 | 39,319 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.68 per share. | 15 Mar 2025 | 78 | 17,594 (0%) | 0% | 258.7 | 20,177 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 218.53 per share. | 15 Sep 2024 | 3,604 | 16,865 (0%) | 0% | 218.5 | 787,582 | Common Stock Class A |
| CME Group | Lynne C. Fitzpatrick | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.99 per share. | 15 Sep 2024 | 754 | 13,261 (0%) | 0% | 217.0 | 163,610 | Common Stock Class A |
| CME Group | Lynne Fitzpatrick C. | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 217.50 per share. | 15 Mar 2024 | 559 | 14,344 (0%) | 0% | 217.5 | 121,583 | Common Stock Class A |
| CME Group | Lynne Fitzpatrick C. | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.50 per share. | 15 Mar 2024 | 248 | 14,096 (0%) | 0% | 217.5 | 53,940 | Common Stock Class A |
| CME Group | Lynne Fitzpatrick C. | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.51 per share. | 15 Mar 2024 | 81 | 14,015 (0%) | 0% | 217.5 | 17,618 | Common Stock Class A |